PGRMC2 and ovarian carcinoma: Our present observations on the P4 receptor expression pattern in CRC are consistent with the recently reported marginal expression of PGR, with low expression levels of mPRβ, mPRγ, and PGRMC2, and abundant expression levels of PGRMC1 in high-grade human ovarian cancer [29].